🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Pennsylvania › York

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell York, PA keessatti

Qorannoo 15 Kansara Qara'a Non-Small Cell f York fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Namoota walitti qabaa jiraSadarkaa 2
  • Cancer Care Associates Of York /ID# 270971, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06568939

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • WellSpan Health-York Cancer Center, York
  • WellSpan Health-York Hospital, York
  • UPMC Memorial, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • WellSpan York Cancer Center, York
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Namoota walitti qabaa jiraSadarkaa 3
  • WellSpan Oncology Research, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07361510

Pan-tumor MRD Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Cancer Care Associates of York (CCAY), York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06605404

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06692738

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • WellSpan Medical Oncology & Hematology at York Cancer Center, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • WellSpan Health-York Cancer Center, York
  • UPMC Memorial, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Cancer Care Associates of York, York
  • WellSpan Health-York Cancer Center, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Cancer Care Associates of York, York
  • WellSpan Health-York Cancer Center, York
  • WellSpan Health-York Hospital, York
18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Namoota walitti qabaa jiraQorannoo ilaalaa
  • WellSpan Health - York Cancer Center, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Cancer Care Associates of York, York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Gur-2026 · NCT05236114

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cancer Care Associates of York (site 206), York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Mud-2025 · NCT03556228

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo York keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.